srch

Information about facility, team, and investors. Working on biologically active and selective drug candidates directed against biologically well-validated ...

Alnylam Is the Leading RNAi Therapeutics Company. Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an entirely new class of medicines. In 2018, our first medicine, ONPATTRO® (patisiran), became the world’s first approved RNAi therapeutic. Our second medicine, GIVLAARI® (givosiran), was ...

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes.

• Broad Institute• Whitehead Institute for Biomedical Research• Wyss Institute for Biologically Inspired Engineering• Mass General Research Institute

Alnylam Is the Leading RNAi Therapeutics Company. Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an entirely new class of medicines. In 2018, our first medicine, ONPATTRO® (patisiran), became the world’s first approved RNAi therapeutic. Our second medicine, GIVLAARI® (givosiran), was ...

Kiniksa Pharmaceuticals Corp. 100 Hayden Avenue Lexington, MA 02421 USA (781) 431-9100; USA California Kiniksa Pharmaceuticals Corp. 9191 Towne Centre Drive, Suite 330

Boston Scientific was formed June 29, 1979, in Watertown, Massachusetts, as a holding company for a medical products company called Medi-Tech, and to position the company for growth in interventional medicine. Medi-Tech was the brainchild of Itzak Bentov, a Czech-born emigre to Palestine and then to the United States, who worked at the Arthur D ...

Gaps in pandemic preparedness go beyond the bioterrorism space to resistant-bacteria pathogens and viral infections. AMR is a deadly health threat that according to recent estimates takes the lives of 160,000 Americans each year. It is an ongoing pandemic that will worsen unless we are able to provide new technologies to defeat superbugs.

Kiniksa Pharmaceuticals (UK), Ltd. Third Floor 23 Old Bond Street London, UK W1S 4PZ; US Headquarters Kiniksa Pharmaceuticals Corp. 100 Hayden Avenue Lexington, MA 02421 USA (781) 431-9100; USA California Kiniksa Pharmaceuticals Corp. 9191 Towne Centre Drive, Suite 330 San Diego, CA 92122; Bermuda Kiniksa Pharmaceuticals, Ltd. Clarendon House 2 ...

At Blueprint Medicines, we work together in pursuit of one common goal: to dramatically improve the lives of people with genomically defined diseases.

History. The biotechnology industry in Boston dates back to the 1970s, when genetic engineering was developing. Biogen was the first company in Boston focused on biotechnology. In 2008, the governor of Massachusetts announced the Massachusetts Life Sciences Act, promising $1 billion to further the development of the biotech industry.

Boston Scientific was formed June 29, 1979, in Watertown, Massachusetts, as a holding company for a medical products company called Medi-Tech, and to position ...

Transforming the right molecules into the best medicines™. Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines ...

boston scientific corporation, doing business as boston scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, …

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative ...

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates. We are the leader in the development of ...

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines that improve patients’ lives. We have rapidly built a portfolio of high-value candidates across multiple therapeutic areas and are actively seeking additional programs for our diverse pipeline.

Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines that improve patients’ lives. We have rapidly built a portfolio of high-value candidates across multiple therapeutic areas and are actively seeking additional programs for …

Vertex creates new possibilities in medicine to cure diseases and improve people's lives.